Overview

Study of Paclitaxel Micelles for Injection in Chinese Patients With Advanced Solid Tumors.

Status:
Not yet recruiting
Trial end date:
2023-03-01
Target enrollment:
Participant gender:
Summary
A Phase I Study of Dose Escalation and Dose Expansion To Evaluate the Safety态Tolerability态Pharmacokinetics and Preliminary Efficacy of Paclitaxel Micelles for Injection in Chinese Patients With Advanced Solid Tumor.
Phase:
Phase 1
Details
Lead Sponsor:
First Affiliated Hospital of Zhejiang University
Collaborator:
Hangzhou Dihua Biotechnology Co., LTD.
Treatments:
Albumin-Bound Paclitaxel
Paclitaxel